Pneumococcal diversity: Considerations for new vaccine strategies with emphasis on pneumococcal surface protein A (PspA)

Clinical Microbiology Reviews

Volumn 11, Issue 4, 1998, Pages 645-657

  Briles, David E ^a,b,c   Tart, Rebecca Creech ^a   Swiatlo, Edwin ^a   Dillard, Joseph P ^a   Smith, Patricia ^a   Benton, Kimberly A ^a   Ralph, Beth A ^a   Brooks Walter, Alexis ^a   Crain, Marilyn J ^a,b   Hollingshead, Susan K ^a   McDaniel, Larry S ^a  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; EPITOPE; MEMBRANE PROTEIN; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE VACCINE;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; BACTERIAL IMMUNITY; BACTERIAL VIRULENCE; CHILD; CROSS REACTION; EPITOPE MAPPING; GENETIC VARIABILITY; HUMAN; IMMUNOGENICITY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN ISOLATION; REVIEW; STREPTOCOCCUS PNEUMONIAE;

BACTERIA (MICROORGANISMS); PNEUMOCOCCUS; POSIBACTERIA; STREPTOCOCCUS PNEUMONIAE;

EID: 3643135274     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/cmr.11.4.645     Document Type: Review

References (148)

1. Alexander, J. E., R. A. Lock, C. C. A. M. Peeters, J. T. Poolman, P. W. Andrew, T. J. Mitchell, D. Hansman, and J. C. Paton. 1994. Immunization of mice with pneumolysin toxoid confers a significant degree of protection against at least nine serotypes of Streptococcus pneumoniae. Infect. Immun. 62:5683-5688.
2. Amsbaugh, D. F., C. T. Hansen, B. Prescott, P. W. Stashak, D. R. Barthold, and P. J. Baker. 1972. Genetic control of the antibody response to type III pneumococcal polysaccharide in mice. I. Evidence that an X-linked gene plays a decisive role in determining responsiveness. J. Exp. Med. 136:931-949.
3. Reference deleted.
4. Appelbaum, P. C. 1987. World-wide development of antibiotic resistance in pneumococci. Eur. J. Clin. Microbiol. 6:367-377.
5. Austrian, R., R. M. Douglas, G. Shiffman, et al. 1976. Prevention of pneumococcal pneumonia by vaccination. Trans. Assoc. Am. Physicians 89:184-194.
6. Austrian, R., and J. Gold. 1964. Pneumococcal bacteremia with special reference to bacteremic pneumococcal pneumonia. Ann. Intern. Med. 60: 759-776.
7. Austrian, R. A. 1984. Pneumococcal infections, p. 257-288. In R. Germanier (ed.), Bacterial vaccines. Academic Press, Inc., New York, N.Y.
8. Avery, O. T., and W. F. Goebel. 1929. Chemo-immunological studies on conjugated carbohydrate-proteins. II. Immunological specificity of synthetic sugar-protein antigens. J. Exp. Med. 50:533-550.
9. Avery, O. T., and W. F. Goebel. 1933. Chemo-immunological studies of the soluble specific substance of pneumococcus. I. The isolation and properties of the acetyl polysaccharide of pneumococcus type 1. J. Exp. Med. 58:731-755.
10. Avery, O. T., W. F. Goebel, and F. H. Babers. 1932. Chemo-immunological studies on conjugated carbohydrate-proteins. VII. Immunological specificity of antigens prepared by combining α- and β-glucosides of glucose with proteins. J. Exp. Med. 55:769-780.
11. Banks, S. D., and C. J. Lee. 1991. Analysis of pneumolysin in Streptococcus pneumoniae group 19 strains, p. 97. In Abstracts of the 91st General Meeting of the American Society for Microbiology 1991. American Society for Microbiology, Washington, D.C.
12. Benton, K. A., M. P. Everson, and D. E. Briles. 1995. A pneumolysin-negative mutant of Streptococcus pneumoniae causes chronic bacteremia rather than acute sepsis in mice. Infect. Immun. 63:448-455.
13. Benton, K. A., J. C. Paton, and D. E. Briles. 1997. Differences in virulence of mice among Streptococcus pneumoniae strains of capsular types 2, 3, 4, 5, and 6 are not attributable to differences in pneumolysin production. Infect. Immun. 65:1237-1244.
14. Berry, A. M., J. Yother, D. E. Briles, D. Hansman, and J. C. Paton. 1989. Reduced virulence of a defined pneumolysin-negative mutant of Streptococcus pneumoniae. Infect. Immun. 57:2037-2042.
15. Breise, T., and R. Hackenbeck. 1985. Interactions of pneumococcal amidase with lipoteichoic acid and choline. Eur. J. Biochem. 146:417-427.
16. Briles, D. E., M. J. Crain, B. M. Gray, C. Forman, and J. Yother. 1992. A strong association between capsular type and mouse virulence among human isolates of Streptococcus pneumoniae. Infect. Immun. 60:111-116.
17. Briles, D. E., C. Forman, and M. Crain. 1992. Mouse antibody to phosphocholine can protect mice from infection with mouse-virulent human isolates of Streptococcus pneumoniae. Infect. Immun. 60:1957-1962.
18. Briles, D. E., C. Forman, J. C. Horowitz, J. E. Volanakis, W. H. Benjamin, Jr., L. S. McDaniel, J. Eldridge, and J. Brooks. 1989. Antipneumococcal effects of C-reactive protein and monoclonal antibodies to pneumococcal cell wall and capsular antigens. Infect. Immun. 57:1457-1464.
19. Briles, D. E., C. Forman, S. Hudak, and J. L. Claflin. 1982. Anti-PC antibodies of the T15 idiotype are optimally protective against Streptococcus pneumoniae. J. Exp. Med. 156:1177-1185.
20. 1 antiphosphorylcholine antibodies to protect mice from fatal infection with Streptococcus pneumoniae. Eur. J. Immunol. 14:1027-1030.
21. Briles, D. E., S. K. Hollingshead, E. Swiatlo, A. Brooks-Walter, A. Szalai, A. Virolainen, L. S. McDaniel, K. A. Benton, P. White, K. Prellner, et al. 1997. PspA and PspC: their potential for use as pneumococcal vaccines. Microb. Drug Resist. 3:401-408.
22. Briles, D. E., and J. F. Kearney. 1985. Idiotype antibodies. Methods Enzymol. 116:174-189.
23. Briles, D. E., J. D. King, M. A. Gray, L. S. McDaniel, E. Swiatlo, and K. A. Benton. 1996. PspA, a protection-eliciting pneumococcal protein: immunogenicity of isolated native PspA in mice. Vaccine 14:858-867.
24. Briles, D. E., M. Nahm, K. Schroer, J. Davie, P. Baker, J. Kearney, and R. Barletta. 1981. Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 Streptococcus pneumoniae. J. Exp. Med. 153:694-705.
25. Briles, D. E., J. S. Sheffield, C. S. Forman, J. D. King, L. S. McDaniel, S. K. Hollingshead, W. H. J. Benjamine, and B. L. Mathews. Unpublished data.
26. Briles, D. E., R. C. Tart, H.-Y. Wu, B. A. Ralph, M. W. Russell, and L. S. McDaniel. 1996. Systemic and mucosal protective immunity to pneumococcal surface protein A. Ann. N. Y. Acad. Sci. 797:118-126.
27. Briles, D. E., J. Yother, and L. S. McDaniel. 1988. Role of pneumococcal surface protein A in the virulence of Streptococcus pneumoniae. Rev. Infect. Dis. 10:S372-S374.
28. 3H-labeled teichoic acid. J. Cell Biol. 47:786-790.
29. Briles, E. B., and A. Tomasz. 1973. Pneumococcal forssman antigen. A choline-containing lipoteichoic acid. J. Biol. Chem. 248:6394-6397.
30. Brooks-Walter, A., L. S. McDaniel, S. K. Hollingshead, and D. E. Briles. Unpublished data.
31. Brooks-Walter, A., R. C. Tart, D. E. Briles, and S. K. Hollingshead. Unpublished data.
32. Brundish, D. E., and J. Baddiley. 1968. Pneumococcal C-substance, a ribitol teichoic acid containing choline phosphate. Biochem. J. 110:373-582.
33. Butler, J. C., J. Hofmann, M. S. Cetron, J. A. Elliott, R. R. Facklam, and R. F. Breiman. 1996. The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the Centers for Disease Control and Prevention's pneumococcal sentinel surveillance system. J. Infect. Dis. 174:986-993.
34. Canvin, J. R., A. P. Marvin, M. Sivakumaran, J. C. Paton, G. J. Boulonois, P. W. Andrew, and T. J. Mitchell. 1995. The role of pneumolysin and autolysin in the pathology of pneumoniae and septicemia in mice infected with a type 2 pneumococcus. J. Infect. Dis. 172:119-123.
35. 34a. Centers for Disease Control. 1989. Pneumococcal polysaccharide vaccine, recommendations of the immunization practices. Morbid. Mortal. Weekly Rep. 38:64-68.
36. Centers for Disease Control and Prevention. 1995. Pneumonia and influenza death rates - United States 1979-1994. Morbid. Mortal. Weekly Rep. 44:535-537.
37. Claflin, J. L., R. Lieberman, and J. M. Davie. 1974. Clonal nature of the immune response to phosphocholine. II. Idiotypic specificity and binding characteristics of anti-phosphocholine antibodies. J. Immunol. 112:1747-1756.
38. Coffey, T. J., C. G. Dowson, M. Daniels, J. Zhou, C. Martin, B. G. Spratt, and J. M. Musser. 1991. Horizontal transfer of multiple penicillin-binding protein genes, and capsule biosynthetic genes, in natural populations of Streptococcus pneumoniae. Mol. Microbiol. 5:2255-2260.
39. Cohen, C., and D. A. D. Parry. 1990. α-Helical coiled coils and bundles: how to design an α-helical protein. Proteins Struct. Funct. Genet. 7:1-15.
40. Cohen, J. 1994. Bumps on the vaccine road. Science 265:1371-1373.
41. Cowan, M. J., A. J. Ammann, D. W. Wara, V. M. Howie, L. Schultz, N. Doyle, and M. Kaplan. 1978. Pneumococcal polysaccharide immunization in infants and children. Pediatrics 62:721-727.
42. Grain, M. J., and D. E. Briles. Unpublished data.
43. Crain, M. J., J. S. Turner, D. A. Robinson, T. J. Coffey, A. Brooks-Walter, L. S. McDaniel, and D. E. Briles. 1996. Evidence for the simultaneous expression of two PspAs by a clone of capsular serotype 6B Streptococcus pneumoniae. Microb. Pathog. 21:265-275.
44. Crain, M. J., W. D. Waltman II, J. S. Turner, J. Yother, D. E. Talkington, L. M. McDaniel, B. M. Gray, and D. E. Briles. 1990. Pneumococcal surface protein A (PspA) is serologically highly variable and is expressed by all clinically important capsular serotypes of Streptococcus pneumoniae. Infect. Immun. 58:3293-3299.
45. Dowson, C. G., A. Hutchinson, J. A. Brannigan, R. C. George, D. Hansman J. Liñares, A. Tomasz, J. Maynard, and B. G. Spratt. 1989. Horizontal transfer of penicillin-binding protein genes in penicillin-resistant clinical isolates of Streptococcus pneumoniae. Proc. Natl. Acad. Sci. USA 86:8842-8846.
46. Dramsi, S., P. Dehoux, and P. Cossart. 1993. Common features of gram-positive bacterial proteins involved in cell recognition. Mol. Microbiol. 9:1119-1122.
47. Elliott, M., and J. F. Kearney. 1992. Idiotype regulation of development of the B-cell repertoire. Ann. N. Y. Acad. Sci. 651:336-345.
48. Farley, J. J., J. C. King, P. Nair, S. E. Hines, R. L. Tressler, and P. E. Vink. 1994. Invasive pneumococcal disease among infected and uninfected children of mothers with immunodeficiency virus infection. J. Pediatr. 124:853-858.
49. Feldman, C., T. J. Mitchell, P. W. Andrew, G. J. Boulnois, R. Raad, H. C. Todd, P. J. Cole, and R. Wilson. 1990. The effect of Streptococcus pneumoniae on human respiratory epithelium in vitro. Microb. Pathog. 9:275-284.
50. Finne, J., D. Bitter-Suermann, C. Goridis, and U. Finne. 1987. An IgG monoclonal antibody to group B meningococci cross-reacts with developmentally regulated polysialic acid units of glycoproteins in neural and extraneural tissues. J. Immunol. 138:4402-4407.
51. Finne, J., M. Leinonen, and P. H. Makela. 1983. Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis. Lancet ii:355-357.
52. Fischetti, V. A., D. A. D. Parry, B. L. Trus, S. K. Hollingshead, J. R. Scott, and B. N. Manjula. 1988. Conformational characteristics of the complete sequence of group A streptococcal M6 protein. Proteins 3:60-69.
53. Gillespie, S. H. 1989. Aspects of pneumococcal infection including bacterial virulence, host response and vaccination. J. Med. Microbiol. 28:237-248.
54. Giudicelli, S., and A. Tomasz. 1984. Attachment of pneumococcal autolysin to wall teichoic acids, an essential step in enzymatic wall degradation. J. Bacteriol. 158:1188-1190.
55. Giudicelli, S., and A. Tomasz. 1984. Inhibition of the in vitro and in vivo activity of the pneumococcal autolytic enzyme - by choline and phosphorylcholine, p. 207-212. In C. Nombela (ed.), Microbial cell wall synthesis and autolysis. Elsevier Science Publishers B.V., Amsterdam, The Netherlands.
56. Goebel, W. F., and M. H. Adams. 1943. The immunological properties of the heterophile antigen and somatic polysaccharide of pneumococcus. J. Exp. Med. 77:435-449.
57. Goebel, W. F., F. H. Babers, and O. T. Avery. 1934. Chemo-immunological studies on conjugated carbohydrate-proteins. VIII. The influence of the acetyl group on the specificity of hexoside-protein antigens. J. Exp. Med. 60:85-94.
58. Gotschlich, E. C., I. Goldschneider, M. L. Lepow, and R. Gold. 1977. The immune response to bacterial polysaccharides in man, p. 391-402. In E. Haber and R. M. Krause (ed.), Antibodies in human diagnosis and therapy. Raven Press, New York, N.Y.
59. Gray, B. M. 1995. Pneumococcal infection in an era of multiple antibiotic resistance. Adv. Pediatr. Infect. Dis. 11:55-100.
60. Gray, B. M., G. M. Converse III, and H. C. Dillon. 1980. Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life. J. Infect. Dis. 142:923-933.
61. Hakenbeck, R., T. Briese, L. Chalkley, H. Ellerbrok, R. Kalliokoski, C. Latorre, M. Leinonen, and C. Martin. 1991. Antigenic variation of penicillin-binding proteins from penicillin-resistant clinical strains of Streptococcus pneumoniae. J. Infect. Dis. 164:313-319.
62. Hakenbeck, R., T. Briese, L. Chalkley, H. Ellerbrok, R. Kalliokoski, C. Latorre, M. Leinonen, and C. Martin. 1991. Variability of penicillin-binding proteins from penicillin-sensitive Streptococcus pneumoniae. J. Infect. Dis. 164:307-312.
63. Hammerschmidt, S., S. R. Talay, P. Brandtzaeg, and G. S. Chhatwal. 1997. SpsA, a novel pneumococcal surface protein with specific binding to secretory immunoglobulin A and secretory component. Mol. Microbiol. 25: 1113-1124.
64. Hayrinen, J., H. Jennings, H. V. Raff, G. Rougon, N. Hanai, R. Gerardy-Schahn, and J. Finne. 1995. Antibodies to polysialic acid and its N-propyl derivative: binding properties and interaction with human embryonal brain glycopeptides. J. Infect. Dis. 171:1481-1490.
65. Henrichsen, J. 1995. Six newly recognized types of Streptococcus pneumoniae. J. Clin. Microbiol. 33:2759-2762.
66. Hobden, J. A., M. Hagenah, R. J. O'Callaghan, and J. M. Hill. 1992. Confirmation of the role of pneumolysin in occular infections with Streptococcus pneumoniae. Investig. Ophthalmol. Visual Sci. 33:1422.
67. Hollingshead, S. K., R. S. Becker, and D. E. Briles. Diversity of PspA: mosaic genes and evidence for past recombination in Streptococcus pneumoniae. Submitted for publication.
68. Hollingshead, S. K., and D. E. Briles. Unpublished data.
69. Insel, R. A., and P. W. Anderson. 1986. Oligosaccharide-protein conjugate vaccines induce and prime for oligoclonal IgG antibody responses to the Haemophilus influenzae b capsular polysaccharide in human infants. J. Exp. Med. 163:262-269.
70. Johnson, M. K., J. A. Hobden, M. Hagenah, R. J. O'Callaghan, and J. M. Hill. 1990. The role of pneumolysin in ocular infections with Streptococcus pneumoniae. Curr. Eye Res. 11:1107-1114.
71. Käythy, H., and J. Eskola. 1996. New vaccines for the prevention of pneumococcal infections. Emerg. Infect. Dis. 2:289-298.
72. Kearney, J. F. 1989. Idiotypic networks, p. 663-676. In W. E. Paul (ed.), Fundamental immunology. Raven Press, New York, N.Y.
73. Kenny, J. J., G. Guelde, R. T. Fisher, and D. L. Longo. 1993. Induction of phosphocholine-specific antibodies in X-linked immune deficient mice: in vivo protection against a Streptococcus pneumoniae challenge. Int. Immunol. 6:561-568.
74. Koeuth, T., J. Versalovic, and J. R. Lupski. 1995. Differential subsequence conservation of interspersed repetitive Streptococcus pneumoniae Box elements in diverse bacteria. Genome Res. 5:408-418.
75. Langermann, S., S. R. Palaszynski, J. E. Burlein, S. Koenig, M. S. Hanson, D. E. Briles, and C. K. Stover. 1994. Protective humoral response against pneumococcal infection in mice elicited by recombinant Bacille Calmette-Guérin vaccines expressing PspA. J. Exp. Med. 180:2277-2286.
76. Lee, C.-J., S. D. Banks, and J. P. Li. 1991. Virulence, immunity, and vaccine related to Streptococcus pneumoniae. Crit. Rev. Microbiol. 18:89-114.
77. Lefever, J. C., G. Faucon, A. M. Sicard, and A. M. Gasc. 1993. DNA fingerprinting of Streptococcus pneumoniae strains by pulse-field gel electrophoresis. Infect. Immun. 31:2724-2728.
78. Lock, R. A., D. Hansman, and J. C. Paton. 1992. Comparative efficacy of autolysin and pneumolysin as immunogens protecting mice against infection by Streptococcus pneumoniae. Microb. Pathog. 12:137-143.
79. Lock, R. A., J. C. Paton, and D. Hansman. 1988. Comparative efficacy of pneumococcal neuraminidase and pneumolysin as immunogens protective against Streptococcus pneumoniae. Microb. Pathog. 5:461-467.
80. Lomholt, H. 1995. Evidence for recombination and an antigenically diverse immunoglobulin A1 protease among strains of Streptococcus pneumoniae. Infect. Immun. 63:4238-4243.
81. Macrina, F. L., R. P. Evans, J. A. Tobian, D. L. Hartley, D. B. Clewell, and K. R. Jones. 1983. Novel shuttle plasmid vehicles for Escherichia-Streptococcus transgeneric cloning. Gene 25:145-150.
82. McDaniel, L. S., and D. E. Briles. 1986. Monoclonal antibodies against surface components of Streptococcus pneumoniae, p. 143-164. In A. J. L. Macario and E. C. de Macario (ed.), Monoclonal antibodies against bacteria. Academic Press, Inc., Orlando, Fla.
83. McDaniel, L. S., and D. E. Briles. 1988. A pneumococcal surface protein (PspB) that exhibits the same protease sensitivity as streptococcal R antigen Infect. Immun. 56:3001-3003.
84. McDaniel, L. S., B. A. Ralph, D. O. McDaniel, and D. E. Briles. 1994. Localization of protection-eliciting epitopes on PspA of Streptococcus pneumoniae between amino acid residues 192 and 260. Microb. Pathog. 17:323-337.
85. McDaniel, L. S., G. Scott, J. F. Kearney, and D. E. Briles. 1984. Monoclonal antibodies against protease sensitive pneumococcal antigens can protect mice from fatal infection with Streptococcus pneumoniae. J. Exp. Med. 160:386-397.
86. McDaniel, L. S., G. Scott, K. Widenhofer, J. M. Carroll, and D. E. Briles. 1986. Analysis of a surface protein of Streptococcus pneumoniae recognized by protective monoclonal antibodies. Microb. Pathog. 1:519-531.
87. McDaniel, L. S., J. S. Sheffield, P. Delucchi, and D. E. Briles. 1991. PspA, a surface protein of Streptococcus pneumoniae, is capable of eliciting protection against pneumococci of more than one capsular type. Infect. Immun. 59:222-228.
88. McDaniel, L. S., J. S. Sheffield, E. Swiatlo, J. Yother, M. J. Cram, and D. E. Briles. 1992. Molecular localization of variable and conserved regions of pspA, and identification of additional pspA homologous sequences in Streptococcus pneumoniae. Microb. Pathog. 13:261-269.
89. McDaniel, L. S., W. D. Waltman II, B. Gray, and D. E. Briles. 1987. A protective monoclonal antibody that reacts with a novel antigen of pneumococcal teichoic acid. Microb. Pathog. 3:249-260.
90. McDaniel, L. S., J. Yother, M. Vijayakumar, L. McGarry, W. R. Guild, and D. E. Briles. 1987. Use of insertional inactivation to facilitate studies of biological properties of pneumococcal surface protein A (PspA). J. Exp. Med. 165:381-394.
91. McNamara, M. K., R. E. Ward, and H. Kohler. 1984. Monoclonal idiotype vaccine against Streptococcus pneumoniae infection. Science 226:1325-1326.
92. Mitchell, T. J., P. W. Andrew, F. K. Saunders, A. N. Smith, and G. J. Boulnois. 1991. Complement activation and antibody binding by pneumolysin via a region of the toxin homologous to a human acute-phase protein. Mol. Microbiol. 5:1883-1888.
93. Mitchell, T. J., F. Mendez, J. C. Paton, P. W. Andrew, and G. J. Boulnois. 1990. Comparison of pneumolysin genes and proteins from Streptococcus pneumoniae types 1 and 2. Nucleic Acids Res. 18:4010.
94. Mosier, D. E., I. M. Zitron, J. Mond, A. Aftab, I. Scher, and W. E. Paul. 1977. Surface immunoglobulin D as a functional receptor for a subclass of B lymphocytes. Immunol. Rev. 37:89-104.
95. Munoz, R., T. Coffey, M. Daniels, C. G. Dowson, G. Laible, J. Casal, R. Hakenbeck, M. Jacobs, J. M. Musser, B. G. Spratt, and A. Tomasz. 1991. Intercontinental spread of a multi-resistant clone of serotype 23F of Streptococcus pneumoniae. J. Infect. Dis. 164:302-306.
96. Munoz, R., J. M. Musser, M. Crain, D. E. Briles, A. Marton, A. J. Parkinson, U. Sorensen, and A. Tomasz. 1992. Geographic distribution of penicillin-resistant clones of Streptococcus pneumoniae: characterization by penicillin-binding protein profile, surface protein A typing, and multilocus enzyme analysis. Clin. Infect. Dis. 15:112-118.
97. Paton, J. C., R. A. Lock, and D. C. Hansman. 1983. Effect of immunization with pneumolysin on survival time of mice challenged with Streptococcus pneumoniae. Infect. Immun. 40:548-552.
98. Paton, J. C., B. Rowan-Kelly, and A. Ferrante. 1984. Activation of human complement by the pneumococcal toxin pneumolysin. Infect. Immun. 43: 1085-1087.
99. Perlmutter, R. M., S. T. Crews, R. Douglas, G. Sorensen, N. Johnson, N. Nivera, P. J. Gearhart, and L. Hood. 1984. The generation of diversity in phosphorylcholine-binding antibodies. Adv. Immunol. 35:1-37.
100. Robbins, J. B., R. Austrian, C.-J. Lee, S. C. Rastogi, G. Schiffman, J. Henrichsen, P. H. Makela, C. V. Broome, R. R. Facklam, R. H. Tiesjema, and J. C. Parke, Jr. 1983. Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups. J. Infect. Dis. 148:1136-1159.
101. Robinson, D. A., S. K. Hollingshead, A. J. Parkinson, D. E. Briles, and M. J. Crain. The IS1167 insertion sequence is a phenotypically informative marker among isolates of serotype 6B Streptococcus pneumoniae. Mol. Evol., in press.
102. Robinson, D. A., J. S. Turner, R. R. Facklam, A. J. Parkinson, R. F. Breiman, M. Gratten, S. K. Hollingshead, D. E. Briles, and M. J. Crain. Molecular characterization of a globally distributed lineage of serotype 12F Streptococcus pneumoniae causing invasive disease. Submitted for publication.
103. Rodriguez-Barradas, M. C., R. A. Tharapel, J. E. Groover, K. P. Giron, C. E. Lacke, E. D. Houston, R. J. Hammill, M. C. Steinhoff, and D. M. Musher. 1997. Colonization by Streptococcus pneumoniae among human immunodeficiency virus-infected adults: prevalence of antibiotic resistance, impact of immunization, and characterization by polymerase chain reaction with box primers of isolates from persistent S. pneumoniae carriers. J. Infect. Dis. 175:590-597.
104. Rosenow, C., P. Ryan, J. N. Weiser, S. Johnson, P. Fontan, A. Ortqvist, and H. R. Masure. 1997. Contribution of novel choline-binding proteins to adherence, colonization and inimunogenicity of Streptococcus pneumoniae. Mol. Microbiol. 25:819-829.
105. Rubins, J. B., D. Charboneau, J. C. Paton, T. J. Mitchell, and P. W. Andrew. 1994. Dual function of pneumolysin in the early pathogenesis of purine pneumococcal pneumonia. J. Clin. Invest. 95:142-150.
106. Rubins, J. B., P. G. Duane, D. Clawson, D. Charboneau, J. Young, and D. E. Niewoehner. 1993. Toxicity of pneumolysin to pulmonary alveolar epithelial cells. Infect. Immun. 61:1352-1358.
107. Russell, H., J. A. Tharpe, D. E. Wells, E. H. White, and J. Johnson. 1990. Monoclonal antibody recognizing a species-specific protein from Streptococcus pneumoniae. J. Clin. Microbiol. 28:2191-2195.
108. Sampson, J. S., S. P. O'Connor, A. R. Stinson, J. A. Tharpe, and H. Russell. 1994. Cloning and nucleotide sequence analysis of psaA, the Streptococcus pneumoniae gene encoding a 37-kilodalton protein homologous to previously reported Streptococcus sp. adhesins. Infect. Immun. 62:319-324.
109. Sanz, J. M., R. Lopez, and J. L. Garcia. 1988. Structural requirements of choline derivatives for 'conversion' of pneumococcal amidase. FEBS Lett. 232:308-312.
110. Schroer, K. R., J. K. Kim, B. Prescott, and P. J. Baker. 1979. Generation of anti-type III pneumococcal polysaccharide hybridomas from mice with an X-linked B lymphocyte defect. J. Exp. Med. 150:689-702.
111. Shapiro, E. D., A. T. Berg, R. Austrian, D. Schroeder, V. Parcells, A. Margolis, R. K. Adair, and J. D. Clemmens. 1991. Protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N. Engl. J. Med. 325: 1453-1460.
112. Sheffield, J. S., W. H. Benjamin, and L. M. McDaniel. 1992. Detection of DNA in Southern blots by chemiluminescence is a sensitive and rapid technique. BioTechniques 12:836-839.
113. 197 conjugated pneumococcal oligosaccharide vaccines in young and elderly adults. Infect. Immun. 65:242-247.
114. Siber, G. R. 1994. Pneumococcal disease: prospects for a new generation of vaccines. Science 265:1385-1387.
115. Steinhoff, M. C., K. Edwards, H. Keyserling, M. L. Thoms, C. Johnson, D. Madore, and D. Hogerman. 1994. A randomized comparison of three bivalent Streptococcus pneumoniae glycoprotein conjugate vaccines in young children: effect of polysaccharide size and linkage characteristics. Pediatr. Infect. Dis. J. 13:368-372.
116. Swiatlo, E., A. Brooks-Walter, D. E. Briles, and L. S. McDaniel. 1997. Oligonucleotides identify conserved and variable regions of pspA and pspA-like sequences of Streptococcus pneumoniae. Gene 188:279-284.
117. Swiatlo, E., M. J. Crain, L. S. McDaniel, A. Brooks-Walter, T. J. Coffey, B. G. Spratt, D. A. Morrison, and D. E. Briles. 1996. DNA polymorphisms and variant penicillin-binding proteins as evidence that relatively penicillin-resistant pneumococci in western Canada are clonally related. J. Infect. Dis. 174:884-888.
118. Szu, S. C., S. Clark, and J. B. Robbins. 1983. Protection against pneumococcal infection in mice conferred by phosphocholine antibodies: specificity of the phosphocholine binding in relation to several types. Infect. Immun. 39:993-999.
119. Takala, A. K., J. Eskola, M. Leinonen, H. Kaythy, A. Nissinen, and E. Pekkanen. 1991. Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine. J. Infect. Dis. 164:982-986.
120. Takala, A. K., J. Vuopio-Varkila, E. Tarkka, M. Leinonen, and J. M. Musser. 1996. Subtyping of common pediatric pneumococcal serotypes from invasive disease and pharyngeal carriage in Finland. J. Infect. Dis. 173:28-135.
121. Talkington, D. F., B. G. Brown, J. A. Tharpe, A. Koening, and H. Russell. 1996. Protection of mice against fatal pneumococcal challenge by immunization with pneumococcal surface adhesion A (PsaA). Mierob. Pathog. 21:17-22.
122. Talkington, D. F., D. L. Crimmins, D. C. Voellinger, J. Yother, and D. E. Briles. 1991. A 43-kilodalton pneumococcal surface protein, PspA: isolation protective abilities, and structural analysis of the amino-terminal sequence. Infect. Immun. 59:1285-1289.
123. Talkington, D. F., D. C. Voellinger, L. S. McDaniel, and D. E. Briles. 1992. Analysis of pneumococcal PspA microheterogeneity in SDS polyacrylamide gels and the association of PspA with the cell membrane. Microb. Pathog. 13:143-355.
124. Tao, L., D. J. LeBlanc, and J. J. Ferretti. 1992. Novel streptococcal-integration shuttle vectors for gene cloning and inactivation. Gene 120:105-110.
125. Tart, R. C., and D. E. Briles. Unpublished data.
126. Tart, R. C., L. S. McDaniel, B. A. Ralph, and D. E. Briles. 1996. Truncated Streptococcus pneumoniae PspA molecules elicit cross-protective immunity against pneumococcal challenge in mice. J. Infect. Dis. 173:380-386.
127. Tharpe, J. A., and H. Russell. 1996. Purification and seroreactivity of pneumococcal surface adhesin A (PsaA). Clin. Diagn. Lab. Immunol. 3:227-229.
128. Tomasz, A. 1968. Biological consequences of the replacement of choline by ethanolamine in the cell wall of pneumococcus: chain formation, loss of transformability, and loss of autolysis. Proc. Natl. Acad. Sci. USA 59:86-93.
129. Tomasz, A. 1981. Surface components of Streptococcus pneumomae. Rev. Infect. Dis. 3:190-211.
130. Vakil, M., D. E. Briles, and J. F. Kearney. 1991. Antigen-independent selection of T15 idiotype during B-cell ontogeny in mice. Dev. Immunol. 1:203-212.
131. Vakil, M., and J. F. Kearney. 1991. Functional relationship between T15 and J558 idiotypes in BALB/c mice. Dev. Immunol. 1:213-224.
132. Vella, P., S. Marburg, J. Staub, P. Kniskern, W. Miller, A. Hagopian, R. Tolman, C. Rusk, L. S. Chupak, and R. Ellis. 1992. Immunogenicity of conjugate vaccines of pneumococcal capsular polysaccharide types 6B, 14, 19F, and 23F with a meningococcal outer membrane protein complex. Infect. Immun. 60:4977-4983.
133. Viering, T. P., and D. P. Fine. 1989. Genetic analysis of Streptococcus pneumoniae serotypes with the use of DNA fingerprinting. J. Infect. Dis. 160:76-82.
134. Walker, J. A., R. L. Allen, P. Falmagne, M. K. Johnson, and G. J. Boulnois. 1987. Molecular cloning, characterization, and complete nucleotide sequence of the gene for pneumolysin, the sulfhydryl-activated toxin of Streptococcus pneumonia?. Infect. Immun. 55:1184-1189.
135. Wallick, S., J. L. Claflin, and D. E. Briles. 1983. Resistance to Streptococcus pneumoniae is induced by a phosphocholine-protein conjugate. J. Immunol. 130:2871-2875.
136. Waltman, W. D. II, B. Gray, L. S. McDaniel, and D. E. Briles. 1988. Cross-reactive monoclonal antibodies for diagnosis of pneumococcal meningitis. J. Clin. Microbiol. 26:1635-1640.
137. Waltman, W. D. II, B. M. Gray, C. Svanborg, R. Facklam, and D. E. Briles. 1991. Epidemiologic studies of group 9 pneumococci in terms of protein type and 9N versus 9V capsular type. J. Infect. Dis. 163:812-818.
138. Waltman, W. D. II, L. S. McDaniel, B. Andersson, L. Bland, B. M. Gray, C. Svanborg-Eden, and D. E. Briles. 1988. Protein serotyping of Streptococcus pneumoniae based on reactivity to six monoclonal antibodies. Microb. Pathog. 5:159-167.
139. Waltman, W. D. II, L. S. McDaniel, B. M. Gray, and D. E. Briles. 1990. Variation in the molecular weight of PspA (pneumococcal surface protein A) among Streptococcus pneumoniae. Microb. Pathog. 8:61-69.
140. Wortham, C., L. Grinberg, D. C. Kaslow, D. E. Briles, L. S. McDaniel, A. Lees, M. Flora, C. M. Snapper, and J. J. Mond. 1998. Enhanced protective antibody responses to PspA after intranasal or subcutaneous injections of PspA genetically fused to granulocyte-macrophage colony-stimulating factor or interleukin-2. Infect. Immun. 66:1513-1520.
141. Wu, H.-Y., M. Nahm, Y. Guo, M. Russell, and D. E. Briles. 1997. Intranasal immunization of mice with PspA (pneumococcal surface protein A) can prevent intranasal carriage and infection with Streptococcus pneumoniae. J. Infect. Dis. 175:893-846.
142. Wu, H.-Y., A. Virolainen, B. Mathews, J. King, M. Russell, and D. E. Briles. 1997. Establishment of a Streptococcus pneumoniae nasopharyngeal model of pneumococcal carriage in adult mice. Microb. Pathog. 23:127-137.
143. Yother, J. Unpublished data.
144. Yother, J., and D. E. Briles. 1992. Structural properties and evolutionary relationships of PspA, a surface protein of Streptococcus pneumoniae, as revealed by sequence analysis. J. Bacteriol. 174:601-609.
145. Yother, J., G. L. Handsome, and D. E. Briles. 1992. Truncated forms of PspA that are secreted from Streptococcus pneumoniae and their use in functional studies and cloning of the pspA gene. J. Bacteriol. 174:610-618.
146. Yother, J., L. S. McDaniel, and D. E. Briles. 1986. Transformation of encapsulated Streptococcus pneumoniae. J. Bacteriol. 168:1463-1465.
147. Yother, J., and J. M. White. 1994. Novel surface attachment mechanism for the Streptococcus pneumoniae protein PspA. J. Bacteriol. 176:2976-2985.
148. Zhou, L., F. M. Hui, and D. A. Morrison. 1995. Characterization of IS1167, a new insertion sequence in Streptococcus pneumoniae. Plasmid 33:127-138.